Skip to main content
OpenTrials

Clinical trial condition

Hemoglobinopathies

Explore clinical trials studying Hemoglobinopathies. Study availability and eligibility vary by location and protocol.

1,050 public trials 168 recruiting studies
Refine in advanced search Browse all conditions

Hemoglobinopathies trial results

Completed

Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol

NCT01783990

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Center for Cancer and Blood Disorders Washington D.C., District of Columbia, United States
  • Howard University College of Medicine Washington D.C., District of Columbia, United States
  • University of Miami School of Medicine Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

Long-Term Effects of Hydroxyurea in Children With Sickle Cell Anemia (The BABY HUG Follow-up Study)

NCT00890396

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Howard University College of Medicine Washington D.C., District of Columbia, United States
  • University of Miami School of Medicine Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia

NCT00006400

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Howard University Washington D.C., District of Columbia, United States
  • University of Miami Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

NCT01179217

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • University of South Alabama Medical Center Mobile, Alabama, United States
  • Phoenix Children's Hospital Center for Cancer and Blood Disorders Phoenix, Arizona, United States
  • Kaiser Permanente Inglewood, California, United States
  • Children's Hospital & Research Center at Oakland Oakland, California, United States
View all 31 locations
View Trial Details

Related conditions